Ann: Application for quotation of securities - NEU, page-9

First 9 Last

Share
Profile

Follow
Saus

996 Posts.

174

28/03/23

12:42

Post #: 66996433
Share

Originally posted by Vapor: ↑

“All loan funded shares under the plan during the year ended 31 December 2021 are subject to the following vesting conditions:
i. 40% of the Loan Funded Shares shall vest on acceptance by the US Food and Drug Administration of the filing of a New Drug Application for Trofinetide; and
ii. 40% of the Loan Funded Shares shall vest when the Company determines to progress NNZ-2591 to a Phase 2b or Phase 3 clinical trial following a positive Phase 2 clinical trial outcome, or executes a partnering transaction for NNZ-2591;
iii. 20% of the Loan Funded Shares shall vest when the Company executes a partnering transaction for trofinetide outside. North America, or submits a Marketing Authorisation Application for trofinetide in the European Union, the United Kingdom, or Japan.”

There was 3,000,000 loan funded shares in the last annual report. 1,500,000 of those were the CEO.
20% of 1,500,000 is 300,000. I’m seeing condition iii being the one met as each of the others would result in the issue of more shares.

Expand

Vapor,
Nice pick-up. maybe Neuren have submitted a Marketing Auth application to European Medicines Agency as a fillip for potential ROW partner?

NEU Price at posting: $13.09 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MEM

Many are concerned about global falling birthrates. This diverse stock has solutions

DYL

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $12.61		Change -0.350(2.70%)		Mkt cap ! $1.574B

Open	High	Low	Value	Volume
$12.82	$13.05	$12.55	$4.708M	366.9K

Buyers (Bids)

No.	Vol.	Price($)
15	3509	$12.60

Sellers (Offers)

Price($)	Vol.	No.
$12.61	26	4

View Market Depth

No.	Vol.	Price($)
2	28	12.590
7	1985	12.580
4	671	12.570
8	4924	12.560
7	4385	12.550

Price($)	Vol.	No.
12.600	415	8
12.610	1248	11
12.620	1922	15
12.630	4002	9
12.640	1532	5

Last trade - 15.20pm 17/06/2025 (20 minute delay)

NEU (ASX) Chart

Ann: Application for quotation of securities - NEU, page-9

Many are concerned about global falling birthrates. This diverse stock has solutions

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Application for quotation of securities - NEU, page-9

Top Stories

Many are concerned about global falling birthrates. This diverse stock has solutions

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News